Gastrointestinal prokinetic agents for enhancing drug response in gastroparesis
نویسندگان
چکیده
منابع مشابه
Evaluation of prokinetic agents used in the treatment of gastroparesis
Background/Aim: Hospitalizations due to gastroparesis have increased in the last 20 years with limited advancements in pharmacologic therapy. Although therapy primarily consists of prokinetic agents, little is known about their effects on hospital outcomes. The aim of our study was to determine whether common prokinetic therapies (metoclopramide and erythromycin) improve outcomes in gastropares...
متن کاملEfficacy of prokinetic agents in diabetic gastroparesis comparing symptomatology and scintigraphy – An open-label trial
Background: It is pertinent to objectively assess the severity of diabetic gastroparesis and tailor treatment accordingly. The current study was planned to document gastroparesis by gastric emptying scintigraphy (GES) objectively and see the effect of medications and diet control on clinical and GES after four weeks. Methods: A prospective, open-label randomized trial was conducted in the Depa...
متن کاملProkinetic agents in critical care
Prokinetic agents are commonly used in intensive care, mainly to aid in early enteral feeding. The present commentary reviews some of the recently published papers and highlights the lack of a sizable evidence base, as well as the possible importance of euglycaemia in this important clinical area.
متن کاملProkinetic effects of mirtazapine on gastrointestinal transit.
Mirtazapine is a noradrenergic and specific serotonergic antidepressant. The aim of this study was to investigate the effects of mirtazapine on gastrointestinal motility in dogs, including solid gastric emptying, antral and small intestinal contractions, and small intestinal and colonic transit. Six dogs were implanted with two cannulas located at the duodenum and the ascending colon; another s...
متن کاملProkinetic Agents and Laryngopharyngeal Reflux Disease
s of all retrieved studies. The full text of the selected studies were then analyzed to ensure that the following inclusion criteria were met: prospective study design, a patient population with a diagnosis of LPR, treatment arm including a prokinetic agent with or without the concomitant use of an antacid therapy (e.g., PPI or H2 antagonist), presence of a comparison arm, and treatment outcome...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Health-System Pharmacy
سال: 1997
ISSN: 1079-2082,1535-2900
DOI: 10.1093/ajhp/54.22.2609